BamSEC and AlphaSense Join Forces
Learn More

Collegium Pharmaceutical Inc. – Indentures

NASDAQ: COLL    
Share price (7/6/26): $37.47    
Market cap (7/6/26): $1.215 billion

Indentures Filter

EX-4.7
from 10-K 3 pages Description of the Registrant’s Common Stock
12/34/56
EX-4.1
from 8-K 107 pages Collegium Pharmaceutical, Inc. and the Bank of New York Mellon Trust Company, N.A. as Trustee Indenture Dated as of February 10, 2023 2.875% Convertible Senior Notes Due 2029
12/34/56
EX-4.5
from 10-K 3 pages Description of the Registrant’s Common Stock
12/34/56
EX-4.5
from 10-K 3 pages Description of the Registrant’s Common Stock
12/34/56
EX-4.5
from 10-K 3 pages Description of the Registrant’s Common Stock
12/34/56
EX-4.2
from 8-K 93 pages Collegium Pharmaceutical, Inc. and the Bank of New York Mellon Trust Company, N.A. as Trustee First Supplemental Indenture Dated as of February 13, 2020 2.625% Convertible Senior Notes Due 2026 Cross Reference Table*
12/34/56
EX-4.1
from 8-K 38 pages Collegium Pharmaceutical, Inc. and the Bank of New York Mellon Trust Company, N.A., as Trustee Indenture Dated as of February 13, 2020
12/34/56
EX-4.5
from S-3 39 pages Collegium Pharmaceutical, Inc. and , as Trustee Indenture Dated as of , I
12/34/56
EX-4.1
from 8-K 15 pages Common Stock Purchase Warrant Collegium Pharmaceutical, Inc
12/34/56
EX-4.6
from S-3 47 pages Collegium Pharmaceutical, Inc. and , as Trustee Indenture Dated as of ,
12/34/56
EX-4.9
from S-1 6 pages Collegium Pharmaceutical, Inc. Amendment No. 1 to the Sixth Amended and Restated Stockholders Agreement
12/34/56
EX-4.8
from S-1 11 pages Warrant to Purchase Stock
12/34/56
EX-4.7
from S-1 11 pages Warrant to Purchase Stock
12/34/56
EX-4.6
from S-1 13 pages Article 1 Exercise
12/34/56
EX-4.5
from S-1 7 pages Preferred Shareholder Agreement
12/34/56
EX-4.4
from S-1 43 pages Collegium Pharmaceutical, Inc. Eighth Amended and Restated Investor Rights Agreement
12/34/56
EX-4.3
from S-1 32 pages Collegium Pharmaceutical, Inc. Seventh Amended and Restated Stockholders Agreement
12/34/56
EX-4.2
from S-1 6 pages Convertible Promissory Note
12/34/56
EX-4.9
from DRS 6 pages Collegium Pharmaceutical, Inc. Amendment No. 1 to the Sixth Amended and Restated Stockholders Agreement
12/34/56
EX-4.8
from DRS 11 pages Warrant to Purchase Stock
12/34/56